via Shirley Ryan AbilityLab
A team of scientists — led by Yamin Zhang, PhD, and Colin Franz, MD, PhD, at Shirley Ryan AbilityLab and John Rogers, PhD, at Northwestern University — has developed novel technology with the potential to change the future of drug delivery.
The device developed represents the first implantable drug delivery system that is triggered by external light sources of different wavelengths, and not by electronics. It also is the first to be absorbable by the body (avoiding surgical extraction) while still allowing active control and programming by the operator (e.g., a doctor, nurse or patient). A study highlighting the device has been published today in the Proceedings of the National Academy of Sciences (PNAS).
“This technology represents a breakthrough addressing shortfalls of current drug delivery systems — one that could have important and sweeping implications for everything from the opioid epidemic to how cancer treatments are precisely delivered,” said Colin Franz, MD, PhD, physician-scientist at Shirley Ryan AbilityLab.
Current implantable drug delivery systems are used to treat medical conditions ranging from chronic pain and muscle spasticity to cancer and diabetes. Passive systems enable gradual release of drugs and don’t require extraction at the end of their use, but they cannot be actively controlled by the user (e.g., turning drug delivery off, up or down). Conversely, active systems that allow programmable drug release require power supplies and electronic parts, and eventually require a second surgery for device extraction.
To test this novel technology, researchers surgically implanted it into the right sciatic nerve of individual rats. Each device contained three drug reservoirs filled with lidocaine, a common nerve-pain-blocking drug. Then, three LEDs were placed over the implantation sites to trigger release of the drug. Subsequent testing showed marked pain relief among the rats. Moreover, researchers were able to achieve different patterns of pain relief depending on the LED color-light sequencing.
“We found this approach to be an effective, safe and non-addictive alternative to systemically delivered pain medications,” said Northwestern University’s John Rogers, PhD. “Additionally, it can be scaled. Although we used a combination of three LEDs in our proof-of-concept testing, moving forward we can potentially increase it up to 30 different LED wavelengths, offering many more programs for pain relief.”
In future studies, the scientific team will review various safety elements prior to seeking U.S. Food and Drug Administration (FDA) clearance for human clinical trials.
“This technology has many promising implications in rehabilitation medicine and beyond, and the collaboration among physicians, material scientists and biomedical engineers at Shirley Ryan AbilityLab and Northwestern University is rapidly accelerating clinically relevant discoveries,” said Dr. Franz, who also is an assistant professor of Physical Medicine and Rehabilitation and Neurology at Northwestern University Feinberg School of Medicine.
The Latest Updates from Bing News
Go deeper with Bing News on:
Implantable drug delivery system
- Silo Pharma's ketamine implant for fibromyalgia shows promise
Silo Pharma’s dissolvable ketamine implant, initially targeting fibromyalgia and chronic pain, has seen success in early research.
- Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
Initial indications target fibromyalgia and chronic painLoaded and encapsulated drug maintains structural stability as implantable ...
- Silo Pharma's SP-26 Ketamine Implant Demonstrates Successful Drug Delivery
“Implantable drug delivery systems like SP-26 may provide sustained drug delivery for prolonged periods of time, which is critical for the treatment of chronic pain conditions,” ...
- Radiofrequency-Triggered Release for On-Demand Delivery of Therapeutics From Titania Nanotube Drug-Eluting Implants
The presented strategy is a promising method to develop RF-triggered release from implantable drug delivery systems where emergency and on-demand delivery of therapeutics is required. Drug and ...
- Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight
and heightened awareness regarding sustained and controlled drug delivery systems. The implantable drug delivery devices market in North America is expected to further flourish with recent product ...
Go deeper with Bing News on:
Drug delivery system
- Woman now trial-bound in lethal drug dealing, head-on crash cases
Kayla McCurry, 32, faces charges in cases stemming from a man's drug overdose and a crash that injured a woman in 2021.
- Nanotechnology in Therapeutics
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
- Researchers design novel drug delivery system that could reverse Alzheimer's disease impact
University of North Carolina at Chapel Hill researchers have developed a new drug delivery platform that harnesses helical amyloid fibers designed to untwist and release drugs in response to body ...
- Drug delivery followed by a drug bust
Police didn’t buy her story and she appeared in Macon County Circuit Court Tuesday pleading not guilty to the drug dealing charge. The allegation against her says it involves an amount of ...
- Patient feedback is creating next-gen drug delivery devices
The patient voice has grown in importance, and now it is being applied to develop and deliver more sophisticated drug delivery devices. Ben Hargreaves finds that connected devices can now provide ...